跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diclegis - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Diclegis
Approved
STANDARD
Diclegis
Duchesnay Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5570eccd81982f4e
Company
Duchesnay Inc.
Type
Standard
Approval Details
Approval Id
5570eccd81982f4e
Drug Approval Philippines Name
Diclegis
Product Name
Diclegis
Registration Number
DR-XY48957
Brand Name
Diclegis
Generic Name
Doxylamine Succinate + Pyridoxine Hydrochloride
Dosage Form
Delayed-Release Tablet
Dosage Strength
10mg/10mg
Manufacturer
Duchesnay Inc.
Importer
Embil International Philippines, Inc.
Distributor
Embil International Philippines, Inc.
Company Detail Path
/organization/duchesnay-inc
Issuance Date
22 December 2023
Expiry Date
22 December 2028
Pharmacologic Category
Antihistamine (Aminoalkyl ether)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5570eccd81982f4e
Type
Standard
Back to Philippines FDA Approvals